Real-world efficacy data in patients with type 2 diabetes on Semaglutide

被引：0
|
作者：
Zitterl, Andreas [1 ,2 ]
Peric, Slobodan [1 ,2 ]
Pichler, Maximilian [1 ]
Prager, Margarete [2 ]
Prager, Rudolf [1 ,2 ]
Stulnig, Thomas [1 ,2 ]
机构：
[1] Clin Hietzing, Dept Med 3, Vienna, Austria
[2] Karl Landsteiner Inst Metab Dis & Nephrol, Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2022年 / 134卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
62
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [1] Semaglutide in Patients with Type 2 Diabetes: Real-World Data from Spain
    Cardenas-Salas, Jersy J.
    Sierra, Roberto
    Luiza Luca, Bogdana
    Sanchez, Begona
    Modrono, Naiara
    Casado, Carlos
    Sanchez, Nancy M.
    Cruces, Eva
    Vazquez, Clotilde
    DIABETES, 2021, 70
  • [2] Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence
    Singh, Awadhesh Kumar
    Singh, Ritu
    Singh, Akriti
    Misra, Anoop
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (05)
  • [3] Efficacy and Safety of Oral Semaglutide in Managing Type 2 Diabetes in India: A Real-World Study
    Ray, Saswati
    Ray, Aparajita
    Goutam, Siddhartha
    Mitra, Asis
    CLINICAL DIABETOLOGY, 2024,
  • [4] Reality of Real-World Experience with Oral Semaglutide in Type 2 Diabetes
    Singh, Awadhesh Kumar
    Singh, Akriti
    Singh, Ritu
    Swain, Jayshree
    CLINICAL DIABETOLOGY, 2024, 13 (06): : 319 - 322
  • [5] A district general hospital real-world experience of the use of semaglutide in patients with type 2 diabetes
    Liarakos, A. L.
    Smith, L.
    Patel, K.
    Mani, H.
    Pierides, M.
    DIABETIC MEDICINE, 2020, 37 : 131 - 131
  • [6] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
    Menzen, Markus
    Berentzen, Tina Landsvig
    Catarig, Andrei-Mircea
    Pieperhoff, Sebastian
    Simon, Joerg
    Jacob, Stephan
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (04) : 205 - 215
  • [7] Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study
    de Lucas, Maria Dolores Garcia
    Caballero, Irene
    Fernandez-Garcia, Jose Carlos
    Dominguez-Rodriguez, Manuel
    Moreno-Moreno, Paloma
    Jimenez-Millan, Anabel
    Botana-Lopez, Manuel
    Aviles, Beatriz
    Merino-Torres, Juan Francisco
    Soto, Alfonso
    Tejera, Cristina
    Morales, Cristobal
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [8] Semaglutide in Patients with Type 2 Diabetes: Real-World Analysis in the Canadian LMC Diabetes Registry: The SPARE Study
    Brown, Ruth E.
    Liu, Aiden R.
    Mahbubani, Reena
    Aronson, Ronnie
    DIABETES, 2019, 68
  • [9] Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice
    Perez-Belmonte, Luis M.
    Sanz-Canovas, Jaime
    de Lucas, Maria D. Garcia
    Ricci, Michele
    Aviles-Bueno, Beatriz
    Cobos-Palacios, Lidia
    Perez-Velasco, Miguel A.
    Lopez-Sampalo, Almudena
    Bernal-Lopez, M. Rosa
    Jansen-Chaparro, Sergio
    Miramontes-Gonzalez, Jose P.
    Gomez-Huelgas, Ricardo
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme
    Yale, Jean-Francois
    Major-Pedersen, Atheline
    Catarig, Andrei-Mircea
    Jain, Rashmi
    Menzen, Markus
    Holmes, Patrick
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4429 - 4440
12345